Please enable JavaScript to continue using this application.

Compare $EVMN vs $SION | Chartloom

Compare

$EVMN vs $SION

Evommune Inc · Sionna Therapeutics Inc

EVMN

Evommune Inc

SION

Sionna Therapeutics Inc

Compare $EVMN vs $SION

Comparing Evommune Inc and Sionna Therapeutics Inc

EVMNEvommune Inc

SIONSionna Therapeutics Inc

EVMNEvommune Inc

Market cap

$225M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-63.9%

52W performance

-69.1%

FCF yield

-55.4%

SIONSionna Therapeutics Inc

Market cap

$221M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-87.5%

52W performance

-82.8%

FCF yield

-34.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

EVMN

SION

Detailed metrics comparison

EVMN

Evommune Inc

SION

Sionna Therapeutics Inc

Market Cap

EVMN$225M

SION$221M

Enterprise Value

EVMN$166M

SION$158M

Price

EVMN$6.25

SION$4.90

P/E Ratio

EVMNN/A

SIONN/A

P/S Ratio

EVMN14.07x

SION0.00x

EV/Sales

EVMN10.38x

SION0.00x

EV/EBITDA

EVMN0.00x

SION0.00x

P/B Ratio

EVMN0.90x

SION0.84x

P/FCF Ratio

EVMNN/A

SIONN/A

EV/FCF

EVMN-1.33x

SION-2.07x

PEG Ratio

EVMNN/A

SIONN/A

Forward P/E (NTM)

EVMNN/A

SIONN/A

Forward P/S (NTM)

EVMNN/A

SIONN/A

Revenue (TTM)

EVMN$16M

SION$0

Revenue Growth (YoY)

EVMNN/A

SIONN/A

Forward Rev Growth

EVMN881.5%

SION1297.1%

Gross Margin (TTM)

EVMN0.0%

SION0.0%

Operating Margin (TTM)

EVMN0.0%

SION0.0%

EBITDA Margin (TTM)

EVMN-1097.9%

SION0.0%

Net Margin (TTM)

EVMN-943.2%

SION0.0%

FCF Margin (TTM)

EVMN-779.8%

SIONN/A

Net Income (TTM)

EVMN$-151M

SION$-97M

FCF (TTM)

EVMN$-125M

SION$-76M

EPS (TTM)

EVMN-$4.18

SION-$2.16

ROE (TTM)

EVMN-4676.0%

SION-3294.0%

ROA (TTM)

EVMN-4337.0%

SION-3108.0%

ROIC (TTM)

EVMN-4661.0%

SION-3294.0%

Cash

EVMN$60M

SION$63M

Debt

EVMN$952K

SION$0

Net Cash/Debt

EVMN$59M

SION$63M

Current Ratio (TTM)

EVMN11.68x

SION20.05x

Quick Ratio (TTM)

EVMN11.48x

SION19.57x

Debt/Equity (TTM)

EVMN0.00x

SION0.00x

Debt/Assets (TTM)

EVMN0.0%

SION0.0%

Interest Coverage (TTM)

EVMNN/A

SIONN/A

Net Debt/EBITDA (TTM)

EVMN0.00x

SION0.00x

Beta

EVMN0.62

SION1.44

52W Performance

EVMN-69.1%

SION-82.8%

YTD Performance

EVMN-63.9%

SION-87.5%

% from 52W High

EVMN-81.2%

SION-91.1%

% from 52W Low

EVMN3.8%

SION22.2%

Asset Turnover (TTM)

EVMN0.00x

SION0.00x

FCF Yield (TTM)

EVMN-55.4%

SION-34.4%

Earnings Yield (TTM)

EVMN-67.0%

SION-44.0%

Dividend Yield (TTM)

EVMNN/A

SIONN/A

Rule of 40

EVMN-779.8

SION0.0

EV/GP/RG

EVMNN/A

SIONN/A

Ticker research

View EVMN research View SION research

Metric	EVMN Evommune Inc	SION Sionna Therapeutics Inc
Market & Valuation
Market Cap	$225M	$221M
Enterprise Value	$166M	$158M
Price	$6.25	$4.90
P/E Ratio	N/A	N/A
P/S Ratio	14.07x	0.00x
EV/Sales	10.38x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.90x	0.84x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.33x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$16M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	881.5%	1297.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1097.9%	0.0%
Net Margin (TTM)	-943.2%	0.0%
FCF Margin (TTM)	-779.8%	N/A
Net Income (TTM)	$-151M	$-97M
FCF (TTM)	$-125M	$-76M
EPS (TTM)	-$4.18	-$2.16
ROE (TTM)	-4676.0%	-3294.0%
ROA (TTM)	-4337.0%	-3108.0%
ROIC (TTM)	-4661.0%	-3294.0%
Financial Health
Cash	$60M	$63M
Debt	$952K	$0
Net Cash/Debt	$59M	$63M
Current Ratio (TTM)	11.68x	20.05x
Quick Ratio (TTM)	11.48x	19.57x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	1.44
52W Performance	-69.1%	-82.8%
YTD Performance	-63.9%	-87.5%
% from 52W High	-81.2%	-91.1%
% from 52W Low	3.8%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-55.4%	-34.4%
Earnings Yield (TTM)	-67.0%	-44.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-779.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EVMN research	View SION research

Valuation

P/S Ratio

SION

0.00x

EVMN

14.07x

EV/FCF

SION

-2.07x

EVMN

-1.33x

Growth & revenue

Forward Revenue Growth

SION

1297.1%

EVMN

881.5%

Profitability & performance

Gross Margin

EVMN

0.0%

SION

0.0%

ROE

SION

-3294.0%

EVMN

-4676.0%

FCF Yield %

SION

-34.4%

EVMN

-55.4%

52-Week Performance

EVMN

-69.1%

SION

-82.8%

Detailed metrics comparison

EVMN

Evommune Inc

SION

Sionna Therapeutics Inc

Market Cap

EVMN$225M

SION$221M

Enterprise Value

EVMN$166M

SION$158M

Price

EVMN$6.25

SION$4.90

P/E Ratio

EVMNN/A

SIONN/A

P/S Ratio

EVMN14.07x

SION0.00x

EV/Sales

EVMN10.38x

SION0.00x

EV/EBITDA

EVMN0.00x

SION0.00x

P/B Ratio

EVMN0.90x

SION0.84x

P/FCF Ratio

EVMNN/A

SIONN/A

EV/FCF

EVMN-1.33x

SION-2.07x

PEG Ratio

EVMNN/A

SIONN/A

Forward P/E (NTM)

EVMNN/A

SIONN/A

Forward P/S (NTM)

EVMNN/A

SIONN/A

Revenue (TTM)

EVMN$16M

SION$0

Revenue Growth (YoY)

EVMNN/A

SIONN/A

Forward Rev Growth

EVMN881.5%

SION1297.1%

Gross Margin (TTM)

EVMN0.0%

SION0.0%

Operating Margin (TTM)

EVMN0.0%

SION0.0%

EBITDA Margin (TTM)

EVMN-1097.9%

SION0.0%

Net Margin (TTM)

EVMN-943.2%

SION0.0%

FCF Margin (TTM)

EVMN-779.8%

SIONN/A

Net Income (TTM)

EVMN$-151M

SION$-97M

FCF (TTM)

EVMN$-125M

SION$-76M

EPS (TTM)

EVMN-$4.18

SION-$2.16

ROE (TTM)

EVMN-4676.0%

SION-3294.0%

ROA (TTM)

EVMN-4337.0%

SION-3108.0%

ROIC (TTM)

EVMN-4661.0%

SION-3294.0%

Cash

EVMN$60M

SION$63M

Debt

EVMN$952K

SION$0

Net Cash/Debt

EVMN$59M

SION$63M

Current Ratio (TTM)

EVMN11.68x

SION20.05x

Quick Ratio (TTM)

EVMN11.48x

SION19.57x

Debt/Equity (TTM)

EVMN0.00x

SION0.00x

Debt/Assets (TTM)

EVMN0.0%

SION0.0%

Interest Coverage (TTM)

EVMNN/A

SIONN/A

Net Debt/EBITDA (TTM)

EVMN0.00x

SION0.00x

Beta

EVMN0.62

SION1.44

52W Performance

EVMN-69.1%

SION-82.8%

YTD Performance

EVMN-63.9%

SION-87.5%

% from 52W High

EVMN-81.2%

SION-91.1%

% from 52W Low

EVMN3.8%

SION22.2%

Asset Turnover (TTM)

EVMN0.00x

SION0.00x

FCF Yield (TTM)

EVMN-55.4%

SION-34.4%

Earnings Yield (TTM)

EVMN-67.0%

SION-44.0%

Dividend Yield (TTM)

EVMNN/A

SIONN/A

Rule of 40

EVMN-779.8

SION0.0

EV/GP/RG

EVMNN/A

SIONN/A

Ticker research

View EVMN research View SION research

Metric	EVMN Evommune Inc	SION Sionna Therapeutics Inc
Market & Valuation
Market Cap	$225M	$221M
Enterprise Value	$166M	$158M
Price	$6.25	$4.90
P/E Ratio	N/A	N/A
P/S Ratio	14.07x	0.00x
EV/Sales	10.38x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.90x	0.84x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.33x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$16M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	881.5%	1297.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1097.9%	0.0%
Net Margin (TTM)	-943.2%	0.0%
FCF Margin (TTM)	-779.8%	N/A
Net Income (TTM)	$-151M	$-97M
FCF (TTM)	$-125M	$-76M
EPS (TTM)	-$4.18	-$2.16
ROE (TTM)	-4676.0%	-3294.0%
ROA (TTM)	-4337.0%	-3108.0%
ROIC (TTM)	-4661.0%	-3294.0%
Financial Health
Cash	$60M	$63M
Debt	$952K	$0
Net Cash/Debt	$59M	$63M
Current Ratio (TTM)	11.68x	20.05x
Quick Ratio (TTM)	11.48x	19.57x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	1.44
52W Performance	-69.1%	-82.8%
YTD Performance	-63.9%	-87.5%
% from 52W High	-81.2%	-91.1%
% from 52W Low	3.8%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-55.4%	-34.4%
Earnings Yield (TTM)	-67.0%	-44.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-779.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EVMN research	View SION research